• Ceftolozane/Tazobactam: Evidence and Research Implications

  2026-09-11

  This review examines how ceftolozane/tazobactam combines potent antipseudomonal cephalosporin activity with β-lactamase inhibition to address resistant Gram-negative infections. Its integrated discussion of mechanism, susceptibility, pharmacokinetics, pharmacodynamics, clinical trials, and safety provides a useful framework for interpreting experimental and translational antibacterial research.

• PKH26 Red Fluorescent Cell Linker Kit Guide

  2026-09-10

  The PKH26 Red Fluorescent Cell Linker Kit provides stable red labeling of cell membrane lipid regions for longitudinal cell tracing and proliferation-oriented assays. It is intended for membrane labeling in vitro or in vivo, not for intracellular targets, organelles, or other non-membrane structures.

• AMG 9810 TRPV1 Antagonist Workflows

  2026-09-10

  AMG 9810 provides a selective pharmacological handle for separating TRPV1-driven calcium entry and CGRP secretion from downstream sensory-cell effects. This guide combines practical calcium-imaging and CGRP workflows with a carefully bounded metabolic-stress extension inspired by AMPK–SQSTM1 research.

• Syringin and Sunitinib in Renal Cell Carcinoma

  2026-09-09

  The reference study identifies Syringin as a potential adjunct to sunitinib in renal cell carcinoma (RCC), linking reduced tumor-cell viability, migration, and survival to EGFR/PI3K/Akt pathway modulation. Its integrated use of network pharmacology, molecular docking, bioinformatics, cell assays, and Western blotting provides a mechanistic framework for studying sunitinib sensitivity, although the findings remain preclinical and require validation in additional models.

• A 83-01 (ALK inhibitor) for Reliable Cell Assays

  2026-09-09

  Learn how A 83-01 (ALK inhibitor), SKU A3133, can improve experimental interpretation in viability, proliferation, EMT, and organoid workflows by providing defined TGF-β/Smad pathway inhibition. This scenario-based guide covers mechanism, dosing, stock preparation, assay controls, data interpretation, and practical product-selection criteria.

• Meropenem Workflows for Carbapenem Resistance

  2026-09-08

  Build reproducible susceptibility, resistance, and transmission assays with Meropenem, a β-lactam antibiotic carbapenem designed for broad bacterial challenge studies. This workflow connects PBP inhibition to plasmid surveillance, helping researchers distinguish drug response from mobile carbapenemase-driven resistance.

• Taihangia rupestris Leaves: UPLC-MS/MS and Bioactivity

  2026-09-08

  This 2026 RSC Advances study combines UPLC-MS/MS chemical profiling with orthogonal antioxidant, α-glucosidase inhibition, affinity-screening, and molecular-docking approaches to compare wild and cultivated Taihangia rupestris leaves. Its central finding is that foothill cultivation can produce chemically richer, more active material than wild plants, supporting conservation-oriented sourcing while identifying candidate compounds for further antidiabetic research.

• Deracoxib Workflows for COX-2 Research

  2026-09-07

  Deracoxib supports exposure-aware inflammation assays, canine osteosarcoma viability studies, and combination-treatment screens. This guide translates reference findings into practical dosing, controls, troubleshooting steps, and decision points for separating COX-2 biology from nonspecific cytotoxicity.

• AMG 9810: TRPV1 Antagonism Under Stress

  2026-09-07

  AMG 9810 is a selective TRPV1 antagonist for dissecting calcium entry and neuropeptide signaling. This article develops a stress-aware assay framework that connects sensory neuron experiments with insights from AMPK–SQSTM1 metabolic-stress biology without conflating the two systems.

• Psoralen-Induced Cholestasis via ERK1/2

  2026-09-05

  Chen and colleagues showed that psoralen and isopsoralen, estrogen-like constituents of Psoraleae Fructus, induce cholestatic injury in zebrafish larvae while activating ERK1/2 and disrupting bile acid homeostasis. The study connects phytoestrogenic activity with ERK signaling and provides pharmacologic rescue evidence supporting ERK1/2 as a mechanistic target for further cholestasis research.

• Tamsulosin: α1A Mechanism and Research Uses

  2026-09-04

  Tamsulosin is a selective α1A-adrenergic receptor antagonist used to study smooth muscle relaxation, ureteral stone passage, and postoperative urinary retention. Product-dossier evidence reports improved stone expulsion, higher maximum urinary flow, and approximately 50% lower postoperative retention risk under specified clinical contexts.

• Metabolomics of Carbapenemase-Producing Enterobacterales

  2026-09-04

  The 2025 reference study uses LC-MS/MS metabolomics and machine learning to distinguish carbapenemase-producing from non-producing Enterobacterales through antibiotic-free metabolic signatures. Its findings connect resistance classification with altered cellular pathways and support the development of faster, phenotype-informed diagnostic workflows.

• Chemotherapy Enhances Neoantigen T Cell Therapy

  2026-09-03

  Sagie et al. identify a KRAS.G12V-specific T cell receptor and show that lymphodepleting chemotherapy improves neoantigen-directed T cell killing by increasing immunoproteasome activity and HLA-I expression. The study links chemotherapy-driven remodeling of the tumor immunopeptidome with stronger recognition by TCR-engineered cells, tumor-infiltrating lymphocytes, and T cell engagers.

• Melittin Workflows for GPCR and Apoptosis Research

  2026-09-03

  Melittin provides a practical way to perturb Gs- and Gi-linked signaling while pairing pathway measurements with viability, apoptosis, and migration assays. This workflow translates a glioblastoma lipid-signaling study into controlled experiments that distinguish G protein effects from nonspecific peptide-associated toxicity.

• Azathramycin A in Reliable Cell Assays

  2026-09-02

  A scenario-based guide to using Azathramycin A (SKU BA1060) in cell viability, proliferation, and Mycobacterium tuberculosis research workflows. It covers mechanism, solvent compatibility, stock preparation, assay controls, PK/PD interpretation, and practical supplier-selection criteria.

7615 records 1/508 page Next 12345 下5页 Last page